Susanne Sheehy, BM BCh, MRCP, DTM&H and Joel Meyer, BM BCh, MRCP
The decline in numbers of healthy volunteers who participate in clinical trials has the potential to become a key rate-limiting factor in vaccine development.
B. Rashmi Borah, Nicolle K. Strand, JD, MBioethics, and Kata L. Chillag, PhD
The Bioethics Commission’s recommendations to include research participants with impaired consent capacity provide an ethical foundation for neuroscience.
AMA J Ethics. 2016; 18(12):1192-1198. doi:
10.1001/journalofethics.2016.18.12.nlit1-1612.
Because many complementary and alternative medicine therapies for autism are based on misguided notions of its cause and lack support from scientifically sound studies, physicians should steer parents away from these practices and toward safe, effective, and evidence-based interventions.
AMA J Ethics. 2015; 17(4):375-380. doi:
10.1001/journalofethics.2015.17.4.sect2-1504
There is evidence that some complementary and alternative treatments improve physiological abnormalities in autism and thus hold promise for improving symptoms.
AMA J Ethics. 2015; 17(4):369-374. doi:
10.1001/journalofethics.2015.17.4.sect1-1504.
Drawing Autism, a collection of drawings and paintings by people diagnosed with autism, demonstrates an array of talent and themes as well as providing insight into the artists and autism spectrum disorder.
AMA J Ethics. 2015; 17(4):359-361. doi:
10.1001/journalofethics.2015.17.4.imhl1-1504.
When a seriously ill mature minor and his parent disagree about his receiving an experimental intervention, who should decide what treatment he will receive?
When a seriously ill mature minor and his parent disagree about his receiving an experimental intervention, who should decide what treatment he will receive?
Though there are channels through which terminally ill patients can access some experimental drugs that have not yet received FDA approval for marketing to the public, in general those drugs must already be proven safe and effective.
When a seriously ill mature minor and his parent disagree about his receiving an experimental intervention, who should decide what treatment he will receive?
Jessie Kimbrough-Sugick, MD, MPH, Jessica Holzer, MA, and Eric B. Bass, MD, MPH
Researchers who approach community partners with an agenda already in hand are missing the point of the community-based participatory research enterprise: developing priorities for study together.